Our global market access experts have put together this framework of activities for successful market access. Download the PDF summary.
Read More
In this webinar, we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President &...
Read More
Reflections, highlights and key takeaways from the MedTech Forum 2023
In the second episode of our Global Whispers webinar series, we explored market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) spoke to Shefali Shah...
Read More
We explore some of the key themes o the agenda for The MedTech Forum from MDR to Digital Twins
What does it take to bring a cannabinoid pharmaceutical to market? On Tuesday 23rd May Clare Foy (Global Market Access Director – Mtech Access) was joined by Michael Sassano (CEO...
Read More
What are surrogate endpoints and how can they support the accelerated approval of new medicines? Where and how are surrogate endpoints being used? In which disease areas and markets can...
Read More
Helen Lilley tells us about her experiences and activities as a medical writer at Mtech Access, supporting projects from local communication materials to global value dossiers to HTA submissions.
Heather Wellam (Senior Consultant – Market Access) explains the cost-effectiveness analysis process in Japan, answering FAQs and exploring challenges and opportunities.
As our developers experiment with integrating AI into our tools, we demonstrate the potential (and current limitations) of this technology with ChatGPT
